000 | 01226 a2200325 4500 | ||
---|---|---|---|
005 | 20250516053814.0 | ||
264 | 0 | _c20120425 | |
008 | 201204s 0 0 eng d | ||
022 | _a1472-8206 | ||
024 | 7 |
_a10.1111/j.1472-8206.2011.00986.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchrör, Karsten | |
245 | 0 | 0 |
_aPharmacokinetic basis of the antiplatelet action of prasugrel. _h[electronic resource] |
260 |
_bFundamental & clinical pharmacology _cFeb 2012 |
||
300 |
_a39-46 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPiperazines _xpharmacokinetics |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacokinetics |
650 | 0 | 4 | _aPrasugrel Hydrochloride |
650 | 0 | 4 | _aProdrugs |
650 | 0 | 4 |
_aPurinergic P2Y Receptor Antagonists _xpharmacokinetics |
650 | 0 | 4 |
_aThiophenes _xpharmacokinetics |
700 | 1 | _aSiller-Matula, Jolanta M | |
700 | 1 | _aHuber, Kurt | |
773 | 0 |
_tFundamental & clinical pharmacology _gvol. 26 _gno. 1 _gp. 39-46 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1472-8206.2011.00986.x _zAvailable from publisher's website |
999 |
_c21136326 _d21136326 |